Avalo Therapeutics officer proposes $1.39M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Avalo Therapeutics, Inc. (AVTX) officer Christopher Ryan Sullivan submitted notice of a proposed sale of 70,709 common shares, with an aggregate market value of $1,385,189.31. The remarks state the shares were and will be received upon exercise of stock options over the next three months, with acquisition and payment dates corresponding to the exercise/sale dates.
Key Figures
Key Terms
Aggregate Market Value financial
Exercise of Stock Options financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Rule 10b5-1 date is listed for Christopher Ryan Sullivan’s AVTX notice?
AI-generated analysis. How Rhea-AI works. Not financial advice.